Ashe Andrew D.
Insider CIK 1573163 · AGTC General Counsel · VERV See Remarks · DYAX General Counsel & Sr. VP, Adm.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 225,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 26,999 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 153,278 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 150,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 107,997 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 40,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 27,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 348,828 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 2,681 | $4.15 | $11.1K | 348,828 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 9,000 | — | $0 | 27,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 9,000 | — | $0 | 351,509 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 225,000 | — | $0 | 225,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2024-05-14 | 2024-05-15 | 76,000 | $6.26 | $475.8K | 342,509 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-16 | 182,800 | — | $0 | 182,800 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 10,835 | — | $0 | 153,278 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 33,749 | — | $0 | 26,999 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 51,203 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 10,835 | $2.87 | $31.1K | 266,509 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 51,203 | $1.39 | $71.2K | 221,925 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 33,749 | $1.48 | $49.9K | 255,674 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-12-02 | 2021-12-06 | 4,000 | $32.10 | $128.4K | 170,722 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 21,599 | — | $0 | 21,599 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2017-08-01 | 2017-08-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 237,500 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 23,437 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 20,312 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 18,125 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 78,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer | 2016-01-22 | 2016-01-22 | 331,528 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 38,750 | — | $0 | 17,565 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 625 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 66,000 | — | $0 | 78,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 51,563 | — | $0 | 23,437 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 54,688 | — | $0 | 20,312 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 62,500 | — | $0 | 237,500 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 18,125 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-15 | 5,150 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-21 | 51,563 | — | $0 | 23,437 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-14 | 2016-01-21 | 38,750 | — | $0 | 18,125 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 51,563 | $4.33 | $223.3K | 203,028 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 625 | $2.39 | $1.5K | 34,752 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 5,150 | $1.87 | $9.6K | 39,902 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 62,500 | $15.23 | $951.9K | 331,528 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 66,000 | $10.20 | $673.2K | 269,028 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 54,688 | $3.00 | $164.1K | 151,465 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 38,750 | $1.48 | $57.4K | 96,777 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-14 | 2016-01-15 | 18,125 | $1.41 | $25.6K | 58,027 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2015-08-03 | 2015-08-05 | 62,320 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2015-08-03 | 2015-08-05 | 62,320 | $24.21 | $1.51M | 34,127 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2015-08-03 | 2015-08-05 | 62,320 | $2.06 | $128.4K | 96,447 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2015-03-06 | 2015-03-06 | 2,400 | $15.50 | $37.2K | 34,127 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2015-02-26 | 2015-02-26 | 1,500 | $15.34 | $23.0K | 36,527 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2015-02-18 | 2015-02-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2014-03-03 | 2014-03-03 | 30,000 | — | $0 | 67,500 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2014-03-03 | 2014-03-03 | 30,000 | $10.00 | $300.0K | 36,277 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2014-03-03 | 2014-03-03 | 30,000 | $1.48 | $44.4K | 66,277 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2014-02-27 | 2014-03-03 | 144,000 | — | $0 | 144,000 | SEC↗ |
| DYAX DYAX CORP | A Award | 2014-02-27 | 2014-03-03 | 24,000 | $10.20 | $244.8K | 36,277 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2014-02-26 | 2014-02-26 | 2,723 | $10.10 | $27.5K | 12,277 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2013-08-13 | 2013-08-15 | 11,875 | — | $0 | 18,125 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2013-08-13 | 2013-08-15 | 8,000 | — | $0 | 62,320 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2013-08-13 | 2013-08-15 | 2,000 | — | $0 | 11,200 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2013-08-13 | 2013-08-15 | 10,625 | — | $0 | 86,875 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2013-08-13 | 2013-08-15 | 2,000 | $1.87 | $3.7K | 25,000 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2013-08-13 | 2013-08-15 | 32,500 | $4.30 | $139.8K | 15,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2013-08-13 | 2013-08-15 | 10,625 | $1.48 | $15.7K | 35,625 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2013-08-13 | 2013-08-15 | 11,875 | $1.41 | $16.7K | 47,500 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2013-08-13 | 2013-08-15 | 8,000 | $2.06 | $16.5K | 23,000 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2013-04-01 | 2013-04-01 | 75,000 | — | $0 | 75,000 | SEC↗ |